Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1985-1-3
pubmed:abstractText
The absorption, metabolism, and excretion of 14C-labeled xamoterol (ICI 118,587) has been examined in mice, rats, rabbits, dogs, and humans. There was incomplete absorption by all species after oral administration, ranging from 9% by humans to 36% by dogs. Most of the absorbed radioactivity was eliminated within 24 hr of administration and the renal route predominated. Conjugates of the parent compound were the only observed metabolites in urine, the phenolic glucuronide being the principal animal metabolite and the phenol sulfate being the only human metabolite. There were marked interspecies variations in metabolite patterns and dogs were the only animal species in which the sulfate metabolite was detected. Comparison of the urinary metabolite patterns also showed higher output of the conjugates after oral administration than after intravenous administration, indicating that first pass metabolism was taking place. Little significant change in absorption or metabolism was seen over a range of oral doses; in rats, some saturation of the glucuronide-conjugating mechanism was observed but the sulfate-conjugating mechanism showed little, if any, diminished capacity at high dose levels in dogs. The use of fast atom bombardment mass spectroscopy for the determination of the molecular weight of conjugates is described.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0090-9556
pubmed:author
pubmed:issnType
Print
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
652-60
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:6149919-Adrenergic beta-Agonists, pubmed-meshheading:6149919-Animals, pubmed-meshheading:6149919-Bile, pubmed-meshheading:6149919-Chromatography, Thin Layer, pubmed-meshheading:6149919-Dogs, pubmed-meshheading:6149919-Feces, pubmed-meshheading:6149919-Female, pubmed-meshheading:6149919-Glucuronates, pubmed-meshheading:6149919-Humans, pubmed-meshheading:6149919-Hydrolysis, pubmed-meshheading:6149919-Intestinal Absorption, pubmed-meshheading:6149919-Magnetic Resonance Spectroscopy, pubmed-meshheading:6149919-Male, pubmed-meshheading:6149919-Mice, pubmed-meshheading:6149919-Mice, Inbred C57BL, pubmed-meshheading:6149919-Propanolamines, pubmed-meshheading:6149919-Rabbits, pubmed-meshheading:6149919-Radioimmunoassay, pubmed-meshheading:6149919-Rats, pubmed-meshheading:6149919-Species Specificity, pubmed-meshheading:6149919-Spectrophotometry, Ultraviolet, pubmed-meshheading:6149919-Sulfates, pubmed-meshheading:6149919-Xamoterol
pubmed:articleTitle
The metabolism of ICI 118,587, a partial agonist of beta 1-adrenoceptors, in mice, rats, rabbits, dogs, and humans.
pubmed:publicationType
Journal Article, Comparative Study